SPRAVATO ®▽ (esketamine) nasal spray approved for reimbursement in Ireland for adults with treatment-resistant major depressive disorder - Hospital Professional News
Mental health experts say a nasal spray to help relieve depression should be subsidised to make it more affordable to sufferers.
Esketamine Spravato Nasal Spray 28mg, 28 mg Dose Kit at Rs 5000/box in Sas Nagar
New Spravato FDA Approval Opens The Door to New Patients, Says Sandhya Prashad, M.D. - ketamine.news
Nasenspray gegen schwere Depression | PZ – Pharmazeutische Zeitung